Our understanding of the vitamin D receptor (VDR) and the effects of VDR activation has changed dramatically in recent years, with the publication of several new studies looking at selective VDR activation and effects on the cardio-renal syndrome (CRS).1 These advances have the potential to change the perspective of VDR activation beyond its role in mineral metabolism. Pleiotropic vitamin D effects have come into the focus of interest
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Introduction: The primary focus on vitamin D therapy was to treat metabolic bone disease. Over the p...
Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patie...
Vitamin D receptor (VDR) modulators are used to treat hyperparathyroidism secondary to chronic kidne...
A normal vitamin D status is essential for human health. Vitamin D deficiency is a recognized risk f...
abstractCardiorenal syndrome (CRS) refers to a constellation of conditions whereby heart and kidney ...
The death rate from cardiovascular disease for dialysis patients is much higher than the general pop...
Vitamin D compounds have been used successfully to treat secondary hyperparathyroidism for almost th...
Vitamin D is a common treatment against secondary hyperparathyroidism in renal patients. However, th...
Hyperparathyroidism occurs in most patients during the progression of chronic kidney disease (CKD) a...
Vitamin D is a kind of steroid hormone and is well known for its important role in regulating the le...
Continuously emerging evidence indicates that defi ciencies in 25-hydroxyvitamin D and consequently ...
Replacement of activated vitamin D has been the cornerstone of therapy for secondary hyperparathyroi...
A normal vitamin D status is essential for human health. Vitamin D deficiency is a recognized risk f...
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Introduction: The primary focus on vitamin D therapy was to treat metabolic bone disease. Over the p...
Vitamin D deficiency appears to be an underestimated risk factor for cardiovascular disease in patie...
Vitamin D receptor (VDR) modulators are used to treat hyperparathyroidism secondary to chronic kidne...
A normal vitamin D status is essential for human health. Vitamin D deficiency is a recognized risk f...
abstractCardiorenal syndrome (CRS) refers to a constellation of conditions whereby heart and kidney ...
The death rate from cardiovascular disease for dialysis patients is much higher than the general pop...
Vitamin D compounds have been used successfully to treat secondary hyperparathyroidism for almost th...
Vitamin D is a common treatment against secondary hyperparathyroidism in renal patients. However, th...
Hyperparathyroidism occurs in most patients during the progression of chronic kidney disease (CKD) a...
Vitamin D is a kind of steroid hormone and is well known for its important role in regulating the le...
Continuously emerging evidence indicates that defi ciencies in 25-hydroxyvitamin D and consequently ...
Replacement of activated vitamin D has been the cornerstone of therapy for secondary hyperparathyroi...
A normal vitamin D status is essential for human health. Vitamin D deficiency is a recognized risk f...
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Due to increasing survival rate of cardiac and renal disease patients, Cardiorenal syndrome (CRS), a...
Introduction: The primary focus on vitamin D therapy was to treat metabolic bone disease. Over the p...